:


1. Attie JN. Modified neck dissection in treatment of thyroid cancer: A safe procedure. Eur J Cancer Clin Oncol 24:315, 1988.

2. Ashcraft WM, Van Herle AJ. The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow up study of patients with treated differentiated thyroid cancer. Am J Med 71:806,1981.

3. Ashcraft WM, Van Herle AJ. Management of thyroid nodules. Head Neck 3:216,298,1981.

4. Burman KD, et al. Management of patients with thyroid carcinoma: Application ofthallium-201 scintigraphy and magnetic resonance imaging. J Nucl Med 31:1958, 1990.

5. DeJong SA, et al. Follicular cell predominance in the cytologic examination of dominant thyroid nodules indicates a sixty percent incidence of neopiasia. Surgery 108:794, 1990.

6. Favus MH, et al. Thyroid cancer occurring as a later consequence of head- and neck-irradiation: Evaluation of 1056 patients. N Engi J Med 294:1019, 1976.

7. Gottlieb JA, Hill CS, Jr. Chemotherapy of thyroid cancer with adriamycin: Experience with 30 patients. N Engi J Med 290:193, 1974.

8. Grant SC, et al. Long-term follow-up of patients with benign thyroid fine needle aspiration cytologic diagnosis. Surgery 106:980,1989.

9. Hotter PB, Gottschalk A. Fluorescent thyroid scanning: Scanning without radioisotopes. J Nucl Med 99:117, 1971.

10. Ibanez ML, et al. Thyroid carcinoma, biological behavior and mortality. Cancer 19:1039, 1966.

11. Konrad HR, Canalis RF. Lethal thyroid carcinoma. Arch Otolaryngol Head Neck Surg 104:454, 1978.

12. Lowhagen T, et al. Aspiration biopsy cytology (ABC) in nodules of the thyroid gland suspected to be malignant. Surg Clin North Am 59:3,1979.

13. Mazzaferri EL, et al. Papillary thyroid carcinoma: The impact of therapy in 576 patients. Medicine 56:171,1977.

14. Melvin KEW, et al. Studies in familial (medullary) thyroid carcinoma. In EG Astwood (ed). Proceedings of the Laurentian Hormone Conference. New York: Academic, 1971.

15. Robbins J, et al. Thyroid cancer: A lethal endocrine neoplasm. Ann Intern Med 115:133, 1991.

16. Schneider AB. Radiation-induced thyroid tumors. Endocrinol Metab Clin North Am. 19:495,1990.

17. Schwartz KE, et al. Calcitonin in nonthyroidal cancer. J Clin Endocrinol Metab 49:438, 1979.

18. Soderstrom N. Puncture of goiters for aspiration biopsy. Acta Med Scand 144:237, 1952.

19. Tunbridge WMG, et al. The spectrum of thyroid disease in a community: The Whickham survey. Clin Endocrinol 7:481,1977.

20. Vander JB, et al. The significance of nontoxic thyroid nodules. Ann Intern Med 69:537, 1968.

21. Van Herle AJ. Pathophysiology of thyroid cancer. In LD Greenfield (ed), Thyroid Cancer. Boca Raton, FL: CRC Pr, 1978. Pp. 23.

22. Van Herle AJ, et al. The thyroid nodule. Ann Intern Med 96:221, 1982.

23. Van Herle AJ, Uller RP. Thyroid cancer classification, clinical features, diagnosis and therapy. Pharmacol Ther 2:215,1977.

24. Van Herle AJ, et al. Control of thyroglobulin synthesis and secretion. N Engi J Med 301:239, 307,1979.

25. Van Herle AJ, Brown DG. Thyroglobulin in benign and malignant thyroid disease. In SA Falk (ed). Thyroid Disease, Endocrinology, Surgery, Nuclear Medicine and Radiotherapy. New York: Haven Pubns, 1990,Chap 26.

26. Varma VM, et al. Treatment of thyroid cancer: Death rates after surgery and after surgery followed by sodium iodide I131. JAMA 214:1437,1970.

27. Woolner LB, et al. Classification and prognosis of thyroid carcinoma: A study of 885 cases observed in a thirty year period. Am J Surg 102:354,1961.

28. Young RL, et al. Pure follicular thyroid carcinoma: Impact of therapy in 214 patients. J Nucl Med 21:733, 1980.

: